New Medical Marijuana Policy Is a Catch-22, Researchers Say
Medical research on marijuana probably won't get any easier, experts say, despite a new government policy aimed at boosting the supply of the drug for medical studies.
That means the types of studies that are needed to address the safety and effectiveness of the drug as a medicine could still be a long way off.
Marijuana's legal status as a "Schedule I" drug, which makes it an illegal drug on the federal level, "severely constrains the access and the number and type of people who can do research with cannabis," said Ryan Vandrey, an associate professor of psychiatry and behavioral sciences at The Johns Hopkins University School of Medicine who studies marijuana. "The unfortunate result of that is that we're now in a situation where you have literally millions of people using a drug for which we don't have established safety or efficacy data," Vandrey said.
On Thursday (Aug. 11), the...
This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.
Follow us on Instagram
Connect with us on Linkedin